Clinical Development | Allucent
Home  /  Solutions  /  Clinical Development

Clinical Development

Strategy, solutions and insights to navigate the complexities of drug development

SCROLL

Anchored by deep expertise and a high-touch partnership model, Allucent delivers operational excellence across a breadth of specialized services and therapeutic experience geared toward small and mid-sized biotech companies.

Allucent’s flexible clinical development and regulatory solutions enable our partners to successfully navigate the complexities of managing and conducting early and late-stage multi-national programs through dedicated study start-up and patient engagement teams, tailored onsite, hybrid or DCT clinical monitoring, full-service pharmacovigilance, data management and biometric capabilities, and medical monitoring.

Our global workforce possesses deep clinical and technical experience coupled with a passion for innovative breakthrough science and assisting clients in delivering novel treatments to patients.

Therapeutic Expertise

Allucent provides robust scientific and drug development expertise for complex therapeutic areas, modalities, and devices, with a focus on oncology, neuroscience, infectious disease and vaccines, cell and gene therapy, and rare diseases.

Clinical Strategy

Our clinical strategy services span design and execution of full product development programs, from exploratory IND and first-in-human to IND (or equivalent), clinical development, marketing approval, through to Phase IV post-marketing research.

Study Start-Up & Site Intelligence

We work as your strategic and operational partner to optimize your study recruitment. Our holistic approach enhances site intelligence, thereby increasing confidence in site identification and selection, expediting the start of studies and enabling earlier patient enrollment.

Patient Recruitment & Retention

Our dedicated Patient Engagement team offers tailored strategies to support patient recruitment, engagement, diversity and compliance, working across a range of therapeutic areas and clinical study types, including on-site, decentralized, and hybrid trials.

Study Experience

 

1015+

clinical trials conducted

Trials in

75+

countries worldwide

 

825+

regulatory submissions per year

 

50+

approved and marketed products

Meet Your A-Team

Anita Nelsen

President, Clinical Trial Operations

Anita Nelsen - LinkedIn Page

Angela D. Brady, MHL

SVP, Project Leadership and Client Relations

Angela D. Brady, MHL - LinkedIn Page

Joyce Moore, PhD

Global Head,
Patient Engagement

Joyce Moore, PhD - LinkedIn Page

Christine Khoza

Global Head, Study Start-up & Site Intelligence

Christine Khoza - LinkedIn Page

Explore

Additional Resources

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter